Miss Payel Bhattacharya, was diagnosed with a rare disease von Hippel-Lindau or VHL. It is a genetic form of cancer. VHL patients battle a series of tumors throughout their life. VHL may occur in up ...
Miss Payel Bhattacharya, was diagnosed with a rare disease von Hippel-Lindau or VHL. It is a genetic form of cancer. VHL patients battle a series of tumors throughout their life. VHL may occur in up ...
A novel oral agent may represent a game-changer for patients with von Hippel-Lindau (VHL) disease, a rare genetic disorder that increases the risk of renal cell carcinoma and other cancers, a new ...
The approval was based on data from an open-label phase 2 study which evaluated the efficacy and safety of Welireg in patients with von Hippel-Lindau-associated renal cell carcinoma and other ...
The FDA granted approval to Welireg for the treatment of patients with von Hippel-Lindau-associated kidney cancer, CNS hemangioblastomas and pancreatic neuroendocrine tumors. The Food and Drug ...
The US Food and Drug Administration (FDA) approved belzutifan (Welireg) for adult patients with von Hippel-Lindau disease (VHL) who require therapy for associated renal cell carcinoma (RCC), central ...
The von Hippel–Lindau (vHL) phenotype is variable, which complicates genetic counseling and surveillance. We describe how the rate of new tumor development varies through the lifetimes of vHL patients ...
VHL is a rare genetic disease which puts patients at risk of developing benign blood vessel tumours and several cancers MSD – known as Merck & Co in the US and Canada – has received a US Food and Drug ...
Please provide your email address to receive an email when new articles are posted on . The FDA approved belzutifan for treatment of cancers associated with von Hippel-Lindau disease. The indication ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results